Diversified Healthcare Trust DHC.OQ reported a quarterly adjusted loss of 36 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -43 cents. The lone analyst forecast for the quarter was for a loss of 29 cents per share.
Revenue rose 5% to $379.62 million from a year ago; analysts expected $370.97 million.
Diversified Healthcare Trust's reported EPS for the quarter was a loss of 36 cents.
The company reported a quarterly loss of $87.45 million.
Diversified Healthcare Trust shares had risen by 6.5% this quarter.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 100% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell."
The average consensus recommendation for the specialized reits peer group is "sell."
Wall Street's median 12-month price target for Diversified Healthcare Trust is $2.00
This summary was machine generated from LSEG data February 26 at 08:25 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Dec. 31 2024 | 0.00 | 0.02 | Beat |
Sep. 30 2024 | 0.04 | 0.02 | Missed |
Jun. 30 2024 | 0.02 | 0.03 | Beat |
Mar. 31 2024 | 0.01 | 0.01 | Met |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.